FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Akums Drugs and Pharmaceuticals IPO and OLA Electric.
Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while OLA Electric is a Mainline Book Built Issue proposed to list at BSE, NSE.
Akums Drugs and Pharmaceuticals IPO | OLA Electric | |
---|---|---|
Logo | ![]() |
![]() |
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited |
Kotak Mahindra Capital Company Limited Bofa Securities India Limited Axis Capital Limited SBI Capital Markets Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP ![]() |
DRHP ![]() |
RHP | RHP ![]() |
|
Anchor Investor | ||
IPO Allotment URL |
The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the OLA Electric is . The final issue price of Akums Drugs and Pharmaceuticals IPO is and of OLA Electric is .
Akums Drugs and Pharmaceuticals IPO | OLA Electric | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹646.00 per share | |
Issue Price (Upper) | ₹679.00 per share | |
Issue Price (Final) | ||
Discount (Retail) | ||
Discount (Employee) | ₹64.00 per share | |
Market Lot Size | 22 shares | |
Fresh Issue Size | 1,00,14,727 shares | |
Fresh Issue Size (Amount) | up to ₹680.00 Cr | up to ₹5,500.00 Cr |
OFS Issue Size | 1,73,30,435 shares | 9,51,91,195 shares |
OFS Issue Size (Amount) | up to ₹1,176.74 Cr | |
Issue Size Total | 2,73,45,162 shares | |
Issue Size Total (Amount) | up to ₹1,856.74 Cr |
Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while OLA Electric opens on . The closing date of Akums Drugs and Pharmaceuticals IPO and OLA Electric is Aug 01, 2024, and , respectively.
Akums Drugs and Pharmaceuticals IPO | OLA Electric | |
---|---|---|
Anchor Bid Date | Jul 29, 2024 | |
Issue Open | Jul 30, 2024 | |
Issue Close | Aug 01, 2024 | |
Basis Of Allotment (Tentative) | Aug 02, 2024 | |
Initiation of Refunds (Tentative) | Aug 05, 2024 | |
Credit of Share (Tentative) | Aug 05, 2024 | |
Listing date (Tentative) | Aug 06, 2024 | |
Anchor Lockin End date 1 | Sep 01, 2024 | |
Anchor Lockin End date 2 | Oct 31, 2024 |
Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to OLA Electric P/E ratio of .
Akums Drugs and Pharmaceuticals IPO | OLA Electric | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Ola Electric Mobility Limited Financial Information (Restated)Ola Electric Mobility Limited's revenue increased by 509.89% and profit after tax (PAT) dropped by -87.73% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 84.94% | 85.77% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 0.11%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 3.37%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.69 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | -0.57% |
In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered while in OLA Electric retail investors are offered . Qualified institutional buyers (QIB) are offered in Akums Drugs and Pharmaceuticals IPO and in OLA Electric.
Akums Drugs and Pharmaceuticals IPO | OLA Electric | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | ||
NII | ||
RII | ||
Employee | ||
Others | ||
Total |
Akums Drugs and Pharmaceuticals IPO subscribed in total, whereas OLA Electric subscribed .
Akums Drugs and Pharmaceuticals IPO | OLA Electric | |
---|---|---|
QIB (times) | ||
NII (times) | ||
Big NII (times) | ||
Small NII (times) | ||
RII (times) | ||
Employee (times) | ||
Other (times) | ||
Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|